Liberalized Versus Strict Cow’s Milk Elimination for the Treatment of Children with Eosinophilic Esophagitis

por Teoh, Timothy, Mill, Christopher, Chan, Edmond, Zimmer, Preeti, Avinashi, Vishal
Publicado 2019

Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant

por Gallo, Richard M., Bryant, Ianthe N., Mill, Christopher P., Kaverman, Steven, Riese, David J.
Publicado 2013

First-reported pediatric cases of American ginseng anaphylaxis and allergy

por Erdle, Stephanie C., Chan, Edmond S., Yang, Hyungjun, Vallance, Bruce A., Mill, Christopher, Wong, Tiffany
Publicado 2018

COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada

por Bahremand, Taraneh, Yao, Jiayun Angela, Mill, Christopher, Piszczek, Jolanta, Grant, Jennifer M., Smolina, Kate
Publicado 2023

Diagnosis and management of food allergies: new and emerging options: a systematic review

por O’Keefe, Andrew W, De Schryver, Sarah, Mill, Jennifer, Mill, Christopher, Dery, Alizee, Ben-Shoshan, Moshe
Publicado 2014

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies

por Birdwell, Christine, Fiskus, Warren, Kadia, Tapan M., DiNardo, Courtney D., Mill, Christopher P., Bhalla, Kapil N.
Publicado 2021

C-CARE: comparing two years of anaphylaxis in children treated at the Montreal Children’s Hospital

por Hochstadter, Elana, Clarke, Ann, LaVieille, Sebastien, Alizadehfar, Reza, Mill, Christopher, Asai, Yuka, Eisman, Harley, Ben-Shoshan, Moshe
Publicado 2014

Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer

por Kabir, Farruk M. Lutful, DeInnocentes, Patricia, Agarwal, Payal, Mill, Christopher P., Riese, David J., Bird, R. Curtis
Publicado 2017

C-CARE: comparing three years of anaphylaxis in children treated at the Montreal Children’s Hospital

por De Schryver, Sarah, Hochstadter, Elana, Clarke, Ann, LaVieille, Sebastien, Alizadehfar, Reza, Dery, Alizee, Mill, Christopher, Eisman, Harley, Ben-Shoshan, Moshe
Publicado 2014

Anaphylaxis across two Canadian pediatric centers: evaluating management disparities

por Lee, Alison YM, Enarson, Paul, Clarke, Ann E, La Vieille, Sébastien, Eisman, Harley, Chan, Edmond S, Mill, Christopher, Joseph, Lawrence, Ben-Shoshan, Moshe
Publicado 2016

Draft Genome Sequence of Acetobacter aceti Strain 1023, a Vinegar Factory Isolate

por Hung, John E., Mill, Christopher P., Clifton, Sandra W., Magrini, Vincent, Bhide, Ketaki, Francois, Julie A., Ransome, Aaron E., Fulton, Lucinda, Thimmapuram, Jyothi, Wilson, Richard K., Kappock, T. Joseph
Publicado 2014

Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells

por Fiskus, Warren, Manshouri, Taghi, Birdwell, Christine, Mill, Christopher P., Masarova, Lucia, Bose, Prithviraj, Kadia, Tapan M., Daver, Naval, DiNardo, Courtney D., Borthakur, Gautam, Khoury, Joseph D., Verstovsek, Srdan, Bhalla, Kapil N.
Publicado 2022

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

por Saenz, Dyana T., Fiskus, Warren, Manshouri, Taghi, Rajapakshe, Kimal, Krieger, Stephanie, Sun, Baohua, Mill, Christopher P., DiNardo, Courtney, Pemmaraju, Naveen, Kadia, Tapan, Parmar, Simrit, Sharma, Sunil, Coarfa, Cristian, Qiu, Peng, Verstovsek, Srdan, Bhalla, Kapil N.
Publicado 2016

Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1

por Mill, Christopher P., Fiskus, Warren, Das, Kaberi, Davis, John A., Birdwell, Christine E., Kadia, Tapan M., DiNardo, Courtney D., Daver, Naval, Takahashi, Koichi, Sasaki, Koji, McGeehan, Gerard M., Ruan, Xinjia, Su, Xiaoping, Loghavi, Sanam, Kantarjian, Hagop, Bhalla, Kapil N.
Publicado 2023

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1

por Fiskus, Warren, Daver, Naval, Boettcher, Steffen, Mill, Christopher P., Sasaki, Koji, Birdwell, Christine E., Davis, John A., Das, Kaberi, Takahashi, Koichi, Kadia, Tapan M., DiNardo, Courtney D., Burrows, Francis, Loghavi, Sanam, Khoury, Joseph D., Ebert, Benjamin L., Bhalla, Kapil N.
Publicado 2022

BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma

por Fiskus, Warren, Mill, Christopher P., Perera, Dimuthu, Birdwell, Christine, Deng, Qing, Yang, Haopeng, Lara, Bernardo H., Jain, Nitin, Burger, Jan, Ferrajoli, Alessandra, Davis, John A., Saenz, Dyana T., Jin, Wendy, Coarfa, Cristian, Crews, Craig M., Green, Michael R., Khoury, Joseph D., Bhalla, Kapil N.
Publicado 2021

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)

por Fiskus, Warren, Boettcher, Steffen, Daver, Naval, Mill, Christopher P., Sasaki, Koji, Birdwell, Christine E., Davis, John A., Takahashi, Koichi, Kadia, Tapan M., DiNardo, Courtney D., Jin, Qi, Qi, Yuan, Su, Xiaoping, McGeehan, Gerard M., Khoury, Joseph D., Ebert, Benjamin L., Bhalla, Kapil N.
Publicado 2022

Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

por Fiskus, Warren, Mill, Christopher P., Birdwell, Christine, Davis, John A., Das, Kaberi, Boettcher, Steffen, Kadia, Tapan M., DiNardo, Courtney D., Takahashi, Koichi, Loghavi, Sanam, Soth, Michael J., Heffernan, Tim, McGeehan, Gerard M., Ruan, Xinjia, Su, Xiaoping, Vakoc, Christopher R., Daver, Naval, Bhalla, Kapil N.
Publicado 2023

Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells

por Fiskus, Warren, Cai, Tianyu, DiNardo, Courtney D., Kornblau, Steven M., Borthakur, Gautam, Kadia, Tapan M., Pemmaraju, Naveen, Bose, Prithviraj, Masarova, Lucia, Rajapakshe, Kimal, Perera, Dimuthu, Coarfa, Cristian, Mill, Christopher P., Saenz, Dyana T., Saenz, David N., Sun, Baohua, Khoury, Joseph D., Shen, Yu, Konopleva, Marina, Bhalla, Kapil N.
Publicado 2019

Novel BET protein Proteolysis Targeting Chimera (BET-PROTAC) exerts superior lethal activity than Bromodomain Inhibitor (BETi) against post-myeloproliferative Neoplasm (MPN) Second...

por Saenz, Dyana T., Fiskus, Warren, Qian, Yimin, Manshouri, Taghi, Rajapakshe, Kimal, Raina, Kanak, Coleman, Kevin G., Crew, Andrew P., Shen, Angela, Mill, Christopher P., Sun, Baohua, Qiu, Peng, Kadia, Tapan M., Pemmaraju, Naveen, DiNardo, Courtney, Kim, Mi-Sun, Nowak, Agnieszka J., Coarfa, Cristian, Crews, Craig M., Verstovsek, Srdan, Bhalla, Kapil N.
Publicado 2017